Impact of 6-Month Course of 1 mg Finasteride Tablets on Lipid Profile Levels in Men with Androgenic Alopecia

In 2012, a study conducted by Kermanshah University of Medical Sciences in Iran examined the impact of 1mg finasteride tablets on the lipid profile of 25 men with androgenic hair loss over a 6-month period. The study found that the use of finasteride significantly decreased the fasting plasma level of high-density lipoprotein (HDL) after 6 months of therapy (P<0.001) and significantly increased the fasting plasma level of triglycerides after 3 months of therapy (P=0.014). However, the levels of low-density lipoprotein (LDL) and total cholesterol were not significantly altered. The study concluded that the use of 1mg finasteride tablets for treating androgenic hair loss could potentially lead to complications in the lipid profile by reducing HDL and increasing total cholesterol, possibly due to an increase in testosterone levels caused by finasteride use.